Amsterdam institute for Immunology and Infectious Diseases is supported in its valorisation activities by the IXA AII business development team:

Dilek Yusuf

Pieter Slijkerman

Wim Meijberg

The business development team comprises three members, with Dilek Yusuf dedicated full-time to AII, while Pieter Slijkerman and Wim Meijberg, allocate their focus across multiple research institutes.

Innovation Exchange Amsterdam (IXA)

Innovation Exchange Amsterdam (IXA) serves as the valorization center for Amsterdam UMC, Vrije Universiteit Amsterdam (VU), University of Amsterdam (UvA), and Amsterdam University of Applied Sciences (HvA). IXA offers comprehensive support throughout the entire valorization process, helping you pinpoint the optimal strategy for your innovation or technology.

IXA's services encompass everything from patenting inventions and negotiating research and licensing agreements with industry partners to facilitating the establishment of startup companies based on UMC technologies and negotiating research collaborations with industry leaders.

Learn more here.

When to reach out to the Business Development team?

Feel free to contact the AII Business Development team for inquiries related to:

  • Collaborating with private partners;
  • Seeking private partners (e.g. Public-Private Partnership = PPP grants)
  • Intellectual property
  • Contract research services
  • Valorization/impact strategy (e.g. in grant proposals)

TKI Subsidy for Collaborative Research Projects

Newsitem AII Business Development Team - 04.04.2024: Amsterdam UMC has secured a significant Translational Knowledge Institute (TKI) subsidy through Health~Holland. This funding can be used for collaborative research projects with industrial partners under the Public Private Partnership (PPP) framework. Prospective applicants are advised to initiate discussions with potential partners early on to streamline the proposal preparation process.

Read more.

Collaboration with Inospin

Newsitem AII Business Development Team - 04.03.2023: The AII Business Development team has been in contact with the company Inospin and they have presented a new tool: PubCompare.ai, a search engine for methods and protocols.

PubCompare.ai is to protocol search what PubMed and Web of Science are to abstracts, featuring advanced keyword and semantic search functionalities for intelligent contextual comparisons.

The platform currently hosts a vast repository, referencing over 27 million methods sourced from Open Access papers, preprints, and Patents. Impressively, it covers approximately 75 to 90% of papers cited in PubMed (coverage may vary based on queries).

For those eager to explore this powerful tool, claim your free account or request additional information by contacting Antoine Mahe (antoine.mahe@inospin.com).

Learn more about our Business Development team in this article.

You can reach out to your dedicated business developer directly or contact the general emailaddress (ixa_aii@amsterdamumc.nl).